Latest News from Pro PG

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th September

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered products on a temporary basis: XYL

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a tempora

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021.

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 10mg Tablets until 15th October 2021

If this was written in the USA or European Markets then the title would only be Early Access Program as those markets would be targeted by any Pharmaceutical Company! However many companies may not plan Australia in their global plan or plan Australia at a later stage in their product life cycle. The Australian market is around 25 million population with high global health standards, products in public hospitals are paid for by the hospital budgets and clinical needs of pati

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.